Ratings by B.Riley (Andrew D\'Silva)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2021 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2021 | OnTrak | OTRK | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | OnTrak | OTRK | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2021 | Infinity Pharmaceutical | INFI | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2021 | OptimizeRX | OPRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2020 | Infinity Pharmaceutical | INFI | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2020 | OptimizeRX | OPRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2020 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2020 | Anixa Biosciences | ANIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | CytoSorbents | CTSO | Maintain | Buy (Buy) |
|
Details | ||
| 4/6/2020 | EyePoint Pharmaceuticals, Inc. | EYPT | Downgrade | Neutral (Buy) |
0.76 (13.98) |
1739.47% | Details | |
| 3/13/2020 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | Geron Corporation | GERN | New Coverage | Buy (N/A) |
1.27 (1.36) |
7.09% | Details | |
| 11/18/2019 | Infinity Pharmaceutical | INFI | New Coverage | Buy (N/A) |
0.98 (0.04) |
-95.92% | Details | |
| 9/24/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2019 | CynergisTek | CTEK | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2019 | Adamis Pharmaceuticals | ADMP | Upgrade | Neutral (Sell) |
1.16 (0.78) |
-32.76% | Details | |
| 7/19/2019 | Intricon Corp | IIN | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2019 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Kindred Biosciences | KIN | Downgrade | Neutral (Buy) |
7.87 (9.25) |
17.53% | Details | |
| 7/16/2019 | Adamis Pharmaceuticals | ADMP | Downgrade | Sell (Neutral) |
1.40 (1.16) |
-17.14% | Details | |
| 5/29/2019 | Harrow Health | HROW | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2019 | Cumberland Pharmaceuticals | CPIX | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2019 | Adamis Pharmaceuticals | ADMP | Maintain | Neutral (N/A) |
|
Details | ||
| 5/3/2019 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2019 | AcelRx Pharmaceuticals | ACRX | New Coverage | Buy (N/A) |
3.40 (0.86) |
-74.71% | Details | |
| 3/25/2019 | Alimera Sciences | ALIM | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | ViewRay Inc. | VRAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2019 | OptimizeRX | OPRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2019 | Intricon Corp | IIN | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2019 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2018 | Imprimis Pharmaceuticals | IMMY | New Coverage | Buy (N/A) |
5.95 (5.69) |
-4.37% | Details | |
| 11/26/2018 | Cumberland Pharmaceuticals | CPIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2018 | Adamis Pharmaceuticals | ADMP | Downgrade | Neutral (Buy) |
2.85 (1.40) |
-50.88% | Details | |
| 11/8/2018 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2018 | CryoPort | CYRX | New Coverage | Buy (N/A) |
10.75 (15.49) |
44.09% | Details | |
| 10/3/2018 | Anixa Biosciences | ANIX | New Coverage | Buy (N/A) |
4.65 (3.27) |
-29.68% | Details | |
| 10/1/2018 | ViewRay Inc. | VRAY | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2018 | Sensus Healthcare | SRTS | New Coverage | Buy (N/A) |
7.62 (3.07) |
-59.71% | Details | |
| 8/22/2018 | Intricon Corp | IIN | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2018 | ViewRay Inc. | VRAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2018 | Cumberland Pharmaceuticals | CPIX | Maintain | Buy (N/A) |
|
Details |
